CRLBF - Cresco Labs Inc.
NEXT EARNINGS:
Mar 13, 2026
(in 17 days)
EPS Est: $-0.02
|
Rev Est: $160.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.50
DETAILS
HIGH:
$8.50
LOW:
$2.50
MEDIAN:
$5.50
CONSENSUS:
$5.50
UPSIDE:
439.22%
Market Cap:
347.30M
Volume:
284,445
Avg Volume:
1,102,030
52 Week Range:
0.426-2.3
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.72
Last Dividend:
$N/A
Exchange:
OTC
Country:
US
Employees:
2,900
IPO Date:
2018-12-03
EPS (TTM):
-0.22
P/E Ratio:
-4.24
Revenue (TTM):
724.34M
Total Assets:
1.36B
Total Debt:
639.64M
Cash & Equiv:
137.56M
Rev Growth (5Y):
41.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
123.6%
ROCE:
3.6%
Debt/Equity:
1.35
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-07 | $-0.05 | $-0.03 | -66.7% | $164.9M | $160.9M | +2.5% |
| 2025-08-07 | $-0.05 | $-0.04 | -25.0% | $163.6M | $168.5M | -2.9% |
| 2025-05-30 | $-0.04 | $-0.03 | -33.3% | $165.8M | $170.6M | -2.9% |
| 2025-03-14 | $-0.01 | $-0.01 | 0.0% | $175.9M | $167.6M | +5.0% |
| 2024-11-08 | $-0.02 | $-0.00 | -474.7% | $179.8M | $172.1M | +4.5% |
| 2024-08-08 | $-0.16 | $-0.01 | -1500.0% | $181.2M | $184.4M | -1.7% |
| 2024-05-15 | $-0.02 | $-0.02 | -4.8% | $183.5M | $183.2M | +0.2% |
| 2024-03-15 | $0.01 | $-0.02 | +150.0% | $193.4M | $181.8M | +6.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 724.34M | 770.88M | 842.68M | 821.68M | 476.25M | 128.53M | 43.25M | 10.31M | 0 | 0 | 0 | 0 |
| Net Income | (74.44M) | (175.52M) | (212.05M) | (319.60M) | (102.16M) | (43.20M) | (1.92M) | (85,832) | (108,586) | 47,377 | (117,435) | (202,736) |
| EPS | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 | -0.37 | -0.03 | -2.63 | -3.10 | 1.16 | -3.38 | -5.82 |
| Total Assets | 1.36B | 1.36B | 1.58B | 1.78B | 1.33B | 616.55M | 318.11M | 1,838 | 75,748 | 111,653 | 125,962 | 187,570 |
| Total Debt | 639.64M | 682.76M | 670.17M | 624.74M | 354.58M | 94.88M | 345,000 | 122,199 | 137,158 | 120,220 | 103 | 0 |
| Cash & Equivalents | 137.56M | 103.43M | 119.34M | 223.54M | 136.34M | 49.10M | 131.30M | 27.04M | 1.30M | 0 | 0 | 5,223 |
| Operating Cash Flow | 132.48M | 58.56M | 18.74M | 14.49M | (10.83M) | (25.19M) | (9.92M) | 29,916 | (22,825) | 83,507 | (4,682) | 5,159 |
| Free Cash Flow | 108.99M | 693,489 | (67.39M) | (82.57M) | (91.21M) | (121.31M) | (39.86M) | (4.03M) | (125,457) | 83,507 | (4,682) | 5,159 |
| FCF per Share | 0.32 | 0.00 | -0.23 | -0.31 | -0.43 | -1.03 | -0.67 | -115.74 | -3.61 | 2.40 | -0.13 | 0.15 |
| Book Value | 474.85M | 505.69M | 627.04M | 755.55M | 574.45M | 187.08M | 121.03M | (1.06M) | (921,316) | (762,477) | (889,176) | (880,476) |
| Cash & ST Investments | 137.56M | 103.43M | 119.34M | 223.54M | 136.34M | 49.10M | 131.30M | 27.04M | 1.30M | 0 | 0 | 5,223 |
| ROC Equity | -0.16 | -0.35 | -0.34 | -0.42 | -0.18 | -0.23 | -0.02 | N/A | N/A | N/A | N/A | N/A |